These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11334367)

  • 1. Telomerase activity in patients with chronic myeloid leukemia and lymphoma.
    Bitisik O; Yavuz S; Yasasever V; Dalay N
    Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):3-12. PubMed ID: 11334367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
    Wu K; Lund M; Bang K; Thestrup-Pedersen K
    Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy.
    Keller G; Brassat U; Braig M; Heim D; Wege H; Brümmendorf TH
    Hematol Oncol; 2009 Sep; 27(3):123-9. PubMed ID: 19569255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in myelodysplastic syndromes.
    Gürkan E; Tanriverdi K; Başlamişli F
    Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Telomeres, telomerase and development of cancer].
    Andersen TI
    Tidsskr Nor Laegeforen; 1998 May; 118(13):2043-6. PubMed ID: 9656791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomeres and telomerase in leukaemia and lymphoma.
    Davison GM
    Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo regulation of telomerase activity and telomere length.
    Hathcock KS; Jeffrey Chiang Y; Hodes RJ
    Immunol Rev; 2005 Jun; 205():104-13. PubMed ID: 15882348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple pathways for the regulation of telomerase activity.
    Holt SE; Wright WE; Shay JW
    Eur J Cancer; 1997 Apr; 33(5):761-6. PubMed ID: 9282114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.
    Bechter OE; Eisterer W; Pall G; Hilbe W; Kühr T; Thaler J
    Cancer Res; 1998 Nov; 58(21):4918-22. PubMed ID: 9810000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias.
    Tatematsu K; Nakayama J; Danbara M; Shionoya S; Sato H; Omine M; Ishikawa F
    Oncogene; 1996 Nov; 13(10):2265-74. PubMed ID: 8950994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib.
    Hartmann U; Balabanov S; Ziegler P; Fellenberg J; van der Kuip H; Duyster J; Lipp HP; Bokemeyer C; Kanz L; Brümmendorf TH
    Exp Hematol; 2005 May; 33(5):542-9. PubMed ID: 15850831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activity and telomere detection during early bovine development.
    Betts DH; King WA
    Dev Genet; 1999; 25(4):397-403. PubMed ID: 10570471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
    Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere reduction and telomerase inactivation during neuronal cell differentiation.
    Kruk PA; Balajee AS; Rao KS; Bohr VA
    Biochem Biophys Res Commun; 1996 Jul; 224(2):487-92. PubMed ID: 8702416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells.
    Brassat U; Balabanov S; Bali D; Dierlamm J; Braig M; Hartmann U; Sirma H; Günes C; Wege H; Fehse B; Gontarewicz A; Dikomey E; Borgmann K; Brümmendorf TH
    Exp Hematol; 2011 Jan; 39(1):66-76.e1-2. PubMed ID: 20940029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
    Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
    Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomeres and telomerase in normal and malignant haematopoietic cells.
    Norrback KF; Roos G
    Eur J Cancer; 1997 Apr; 33(5):774-80. PubMed ID: 9282116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of telomerase activity and telomere function in cancer.
    Gordon KE; Parkinson EK
    Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.